ECEIM consensus statement on equine metabolic syndrome [PDF]
Journal of Veterinary Internal Medicine, 2019 Abstract Equine metabolic syndrome (EMS) is a widely recognized collection of risk factors for endocrinopathic laminitis. The most important of these risk factors is insulin dysregulation (ID). Clinicians and horse owners must recognize the presence of these risk factors so that they can be targeted and controlled to reduce the risk ...
Clare MacLeod
doaj +10 more sources
Adipose tissue dysfunction in obese horses with equine metabolic syndrome. [PDF]
Equine Vet J, 2019 Summary Background Obesity is a common feature of equine metabolic syndrome ( EMS ). In other species, obese adipose tissue shows pathological features such as adipocyte hypertrophy, fibrosis, inflammation and impaired insulin ...
Reynolds A +3 more
europepmc +5 more sources
Associations between endocrine disrupting chemicals and equine metabolic syndrome phenotypes. [PDF]
Chemosphere, 2019 Equine Metabolic Syndrome (EMS) is characterized by abnormalities in insulin regulation, increased adiposity and laminitis, and has several similarities to human metabolic syndrome. A large amount of environmental variability in the EMS phenotype is not explained by commonly measured factors (diet, exercise, and season), suggesting that other ...
Durward-Akhurst SA +9 more
europepmc +5 more sources
Equine metabolic syndrome: Etiopathogenesis, diagnostics and therapy [PDF]
Veterinarski Glasnik, 2015 Equine metabolic syndrome (EMS) is a term adopted in 2002 in aim to define the complex pathology involving obesity, insulin resistance and laminitis in horses and ponies. The EMS was terminologically derived upon similar condition in humans. The
Trailović Dragiša R. +2 more
doaj +3 more sources
Use of principle component analysis to quantitatively score the equine metabolic syndrome phenotype in an Arabian horse population. [PDF]
PLoS ONE, 2018 Equine metabolic syndrome (EMS), like human metabolic syndrome, comprises a collection of clinical signs related to obesity, insulin dysregulation and susceptibility to secondary inflammatory disease.
Samantha L Lewis +4 more
doaj +2 more sources
Metabolic effects and pharmacokinetics of oral cannabidiol (CBD) in Connemara ponies following 21 days of treatment [PDF]
Frontiers in Veterinary ScienceIntroductionCannabidiol (CBD) has gained interest in equine medicine due to its potential therapeutic effects. Preclinical studies suggest that CBD may influence metabolic pathways relevant to metabolic syndrome, which present in both human and equine ...
Kata Wermer +11 more
doaj +2 more sources
Equine Metabolic Syndrome: A Complex Disease Influenced by Multifactorial Genetic Factors. [PDF]
Genes (Basel), 2023 Stefaniuk-Szmukier M +2 more
europepmc +2 more sources
Occurrence of equine metabolic syndrome, clinical manifestations, and associated risk factors in Nigeria. [PDF]
J Equine Sci, 2023 Akinniyi OO +6 more
europepmc +2 more sources
Evaluation of Oxidative Stress and Mitophagy during Adipogenic Differentiation of Adipose-Derived Stem Cells Isolated from Equine Metabolic Syndrome (EMS) Horses [PDF]
Stem Cells International, 2018 Mesenchymal stem cells (MSCs) are frequently used in both human and veterinary medicine because their unique properties, such as modulating the immune response and differentiating into multiple lineages, make them a valuable tool in cell-based therapies.
Krzysztof Marycz +3 more
doaj +2 more sources
Equine metabolic syndrome. [PDF]
Vet Rec, 2015 Laminitis is one of the most common and frustrating clinical presentations in equine practice. While the principles of treatment for laminitis have not changed for several decades, there have been some important paradigm shifts in our understanding of laminitis.
Morgan R, Keen J, McGowan C.
europepmc +3 more sources